Health
Handheld Technology from Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings
Early Detection Can Prevent 95% of Vision Loss Cases SEOUL, South Korea, July 25, 2022 /PRNewswire/ -- Diabetic retinopathy is the leading cause of blindness among working-age adults globally.1 With early detection and treatment, as much as 95 percent of vision loss cases can be prevented.2 Com...
2022-07-25 08:30
2383
US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL
* Investigational new drug (IND) approval received by QBiotics, to initiate a Phase II clinical trial investigating tigilanol tiglate in the treatment of patients with Soft Tissue Sarcoma (STS) * The open label trial will evaluate efficacy and dose ranging in patients with advanced or metasta...
2022-07-25 07:09
2149
Vaccines alone aren't enough to combat AMR, claims new WHO report
The Global Hygiene Council (GHC) calls for the use of hygiene practices, such
as handwashing, alongside vaccinations to prevent the spread of infectious
diseases and reduce the impact of antimicrobial resistance (AMR).
LONDON, July 23, 2022 /PRNewswire/ -- A recent report
2022-07-23 00:30
8167
Smallholder Farmers are the Backbone of Global Food Security and Sustainability: Yara International Speaks at the World Economic Forum's New Champion Dialogues 2022
SHANGHAI, July 22, 2022 /PRNewswire/ -- On July 18-19, the World Economic Forum (WEF) held its Annual Meeting of the New Champions (AMNC) 2022 in a virtual format inTianjin. "The Champion Dialogues: Navigating Uncertainty" attracted over 1,100 business leaders, government officials, and non-gover...
2022-07-22 21:15
4719
A CELEBRATION OF EXCELLENCE, HOE KIAN CHOON AND CUCKOO INTERNATIONAL BAGS THREE AWARDS AT THE ASIA PACIFIC ENTERPRISE AWARDS 2022 MALAYSIA
* Hoe Kian Choon, the Founder and CEO of CUCKOO International (MAL) Sdn Bhd named 'Entrepreneur of the Year' in recognition of his passion to positively impact communities through the 'Rent-Subscription Business Model'. * CUCKOO International (MAL) Sdn Bhd takes home a win under the Corpora...
2022-07-22 16:18
3138
Merck Launches its Uptune Program in Asia for Collaborating with Startups
* Application period for the Merck Uptune program starts today * Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing * Selected startups can receive funding of up to € 100,000 TAGUIG, Philippines ...
2022-07-22 15:09
5006
Merck Launches its Uptune Program in Asia for Collaborating with Startups
* Application period for the Merck Uptune program starts today * Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing * Selected startups can receive funding of up to € 100,000 JAKARTA, Indonesia, ...
2022-07-22 14:50
2210
Merck Launches its Uptune Program in Asia for Collaborating with Startups
* Application period for the Merck Uptune program starts today * Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing * Selected startups can receive funding of up to € 100,000 SINGAPORE, July 22,...
2022-07-22 14:37
2150
Congratulations! Kexing Biopharm (688136.SH) was awarded by the" Annual Top 20 Chinese Biopharmaceutical Entreprises"
SHENZHEN, China, July 21, 2022 /PRNewswire/ -- On 12 July 2022, Menet held the award ceremony of the "Annual Top 100 China's Pharmaceutical Entreprises in 2021", in which 5 sub-lists of the pharmaceutical industries had been announced. This event showcased the professionalism and influence of the...
2022-07-21 22:32
2450
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) inMay 2022 – NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire/ -- Karyopha...
2022-07-21 21:25
2596
Mentice publishes the company's interim report for the period April - June 2022
GOTHENBURG, Sweden, July 21, 2022 /PRNewswire/ -- The acquisition of Ankyras is finalized and a large order in the quarter * The order book increased to 108.9 (67.9) MSEK and compared to 87.1 MSEK at the end of 2021. * We acquired all relevant assets relating to Ankyras from Galgo ...
2022-07-21 14:49
1421
SK Inc., declared an interim dividend of KRW1,500 per share, as part of its commitment to shareholder return
* SK Inc. has decided to pay an interim dividend for fifth consecutive year; Despite uncertainties in business environments, SK Inc. maintains its interim dividend at last year's level * While focusing on new growth drivers such as advanced materials and biotech, SK Inc. is committed to ensur...
2022-07-21 13:53
2047
BAXTER HEALTHCARE ANNOUNCES STEVEN FLYNN TO LEAD ASIA PACIFIC REGION
SINGAPORE, July 21, 2022 /PRNewswire/ -- Baxter International, a global medtech
leader, has announced the appointment ofSteven (Steve) Flynn to Senior Vice
President and President Baxter Asia Pacific.
2022-07-21 09:58
3938
Telix Reports Second Quarter 2022 Financial Results
MELBOURNE, Australia, July 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended30 June 2022. All figures are in AUD$ unless otherwise stated. All fi...
2022-07-21 08:34
2262
First report from the world's most ambitious sequencing project
REYKJAVÍK, Iceland, July 20, 2022 /PRNewswire/ -- Scientists at deCODE genetics
a subsidiary of Amgen together with collaborators fromDenmark report on the
whole genome sequences of 150 thousand participants in the UK biobank in a
paper published in the journal Nature today.
2022-07-20 23:00
1288
ABCAM PLC First Half Trading Update
CAMBRIDGE, England, July 20, 2022 /PRNewswire/ -- Abcam plc ("Abcam", "Company", "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following trading update for the six-month period ending 30 June 2022. The Company will release it...
2022-07-20 21:50
2950
VIRALEZE™ Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral Exposure
MELBOURNE, Australia, July 20, 2022 /PRNewswire/ -- Starpharma's broad-spectrum VIRALEZE™ nasal spray has shown protection against infection with the highly transmissible SARS-CoV-2 Omicron variant in a stringent viral challenge model. VIRALEZE™ is a broad-spectrum barrier nasal spray, developed ...
2022-07-20 17:45
1574
Mastercard and AXA Announce Partnership to Build a Sustainable Future through the Priceless Planet Coalition
AXA, the first insurance partner of the Coalition in Hong Kong, will plant trees around the world on behalf of customers who have registered to use Emma by AXA. HONG KONG, July 20, 2022 /PRNewswire/ -- Mastercard and AXA Hong Kong and Macau ("AXA") today announced a partnership to empower AXA's ...
2022-07-20 16:35
2290
BioWorld by Clarivate Explores the Concept of Extending Human Lifespan in New Report
Special report on aging investigates the latest science, key biological drivers and companies driving the development of potential "Fountain of Youth" candidate drugs LONDON, July 20, 2022 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted infor...
2022-07-20 15:00
1292
Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
SAN FRANCISCO, ROCKVILLE, Md. and SUZHOU, China, July 20, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ...
2022-07-20 08:00
2334
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2920
